Matsuda Masaru
CIK 0001798679 Name as filed on the most recent filing
Filed as Matsuda Masaru (25)
36 transaction lines · from 25 filings · filed 2022-06-02 to 2026-08-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
36 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-03 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,230 disposed | 26.12 | 32,123.66 | Form 4, filing 0001628280-26-053754 | |
| 2026-05-04 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 7,372 disposed | 23.27 | 171,543.49 | Form 4, filing 0001798679-26-000002 | |
| 2026-05-04 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 884 disposed | 23.61 | 20,871.77 | Form 4, filing 0001798679-26-000002 | |
| 2026-03-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 6,553 disposed | 25.16 | 164,876.10 | Form 4, filing 0001628280-26-014326 | |
| 2026-03-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,987 disposed | 25.70 | 51,065.90 | Form 4, filing 0001628280-26-014326 | |
| 2026-03-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 193 disposed | 25.91 | 5,001.38 | Form 4, filing 0001628280-26-014326 | |
| 2026-02-27 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 3,325 disposed | 27.95 | 92,933.75 | Form 4, filing 0001628280-26-014326 | |
| 2026-02-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 19,379 disposed | 25.24 | 489,125.96 | Form 4, filing 0001628280-26-005582 | |
| 2026-02-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 8,562 disposed | 24.97 | 213,793.14 | Form 4, filing 0001628280-26-005582 | |
| 2026-02-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 7,983 disposed | 25.50 | 203,553.73 | Form 4, filing 0001628280-26-005582 | |
| 2026-02-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 4,714 disposed | 25.63 | 120,819.82 | Form 4, filing 0001628280-26-005582 | |
| 2025-12-01 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,657 disposed | 30.23 | 50,091.11 | Form 4, filing 0001798679-25-000007 | |
| 2025-11-19 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,561 disposed | 28.50 | 44,488.50 | Form 4, filing 0001798679-25-000006 | |
| 2025-11-19 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 989 disposed | 27.95 | 27,646.60 | Form 4, filing 0001798679-25-000006 | |
| 2025-11-03 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 7,165 disposed | 24.71 | 177,063.63 | Form 4, filing 0001798679-25-000004 | |
| 2025-11-03 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 43 disposed | 25.40 | 1,092.14 | Form 4, filing 0001798679-25-000004 | |
| 2025-09-04 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 36,130 disposed | 16.16 | 583,716.28 | Form 4, filing 0001787306-25-000134 | |
| 2025-08-04 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 6,330 disposed | 14.33 | 90,687.38 | Form 4, filing 0001787306-25-000116 | |
| 2025-05-28 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,800 disposed | 13.78 | 24,806.52 | Form 4, filing 0002065881-25-000011 | |
| 2025-05-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 5,030 disposed | 15.20 | 76,453.48 | Form 4, filing 0001787306-25-000086 | |
| 2025-03-03 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 3,263 disposed | 13.03 | 42,520.48 | Form 4, filing 0001787306-25-000038 | |
| 2025-02-03 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 8,338 disposed | 12.70 | 105,892.60 | Form 4, filing 0001787306-25-000017 | |
| 2024-11-30 |
Arcutis Biotherapeutics, Inc. ARQT |
P, Open-market purchase | 1,657 acquired | 7.11 | 11,774.64 | Form 4, filing 0001787306-24-000168 | |
| 2024-11-19 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,775 disposed | 9.68 | 17,190.34 | Form 4, filing 0001787306-24-000159 | |
| 2024-11-04 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 5,015 disposed | 8.68 | 43,551.26 | Form 4, filing 0001787306-24-000145 | |
| 2024-08-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 5,220 disposed | 9.02 | 47,064.04 | Form 4, filing 0001787306-24-000118 | |
| 2024-05-31 |
Arcutis Biotherapeutics, Inc. ARQT |
P, Open-market purchase | 4,000 acquired | 1.69 | 6,768.00 | Form 4, filing 0001787306-24-000168 | |
| 2024-05-28 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,775 disposed | 9.01 | 15,988.14 | Form 4, filing 0001787306-24-000083 | |
| 2024-05-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 5,016 disposed | 8.74 | 43,828.80 | Form 4, filing 0001787306-24-000069 | |
| 2024-03-04 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 3,760 disposed | 11.12 | 41,815.71 | Form 4, filing 0001787306-24-000042 | |
| 2023-11-21 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,850 disposed | 1.98 | 3,661.15 | Form 4, filing 0001787306-23-000126 | |
| 2023-05-31 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,830 disposed | 7.80 | 14,278.21 | Form 4, filing 0001787306-23-000066 | |
| 2023-03-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,416 disposed | 15.82 | 22,398.43 | Form 4, filing 0001567619-23-004542 | |
| 2023-03-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 18 disposed | 16.52 | 297.36 | Form 4, filing 0001567619-23-004542 | |
| 2022-11-21 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,720 disposed | 18.19 | 31,288.86 | Form 4, filing 0001787306-22-000077 | |
| 2022-06-02 |
Arcutis Biotherapeutics, Inc. ARQT |
S, Open-market sale | 1,795 disposed | 19.73 | 35,418.58 | Form 4, filing 0001567619-22-012149 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 2
- Open-market sale 34
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Matsuda Masaru, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001798679
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6